Joel Vega-Badillo

Joel Vega-Badillo

Auto-generated profile, based on publicly available information

Joel Vega-Badillo

RNA Therapeutics Institute and Howard Hughes Medical Institute, University of Massachusetts Chan Medical School, Worcester, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2023 in Nature
Verified
Journal Article
Open access
PDF file
IGIldar Gainetdinov
Ildar Gainetdinov
JVJoel Vega-Badillo
Joel Vega-Badillo
KCKatharine Cecchini
Katharine Cecchini
ABAyca Bagci
Ayca Bagci
CCCansu Colpan
Cansu Colpan
PZPhillip D. Zamore
Phillip D. Zamore
In eukaryotes, small RNA guides, such as small interfering RNAs and microRNAs, direct AGO-clade Argonaute proteins to regulate gene expression and defend the genome against external threats. Only animals make a second clade of Argonaute proteins: PIWI proteins. PIWI proteins use PIWI-interacting RNAs (piRNAs) to repress complementary transposon transcripts1,2. In theory, transposons could evade silencing through target site mutations that reduce piRNA complementarity. Here we report that, unlike AGO proteins, PIWI proteins efficiently cleave transcripts that are only partially paired to their piRNA guides. Examination of target binding and cleavage by mouse and sponge PIWI proteins revealed that PIWI slicing tolerates mismatches to any target nucleotide, including those flanking the scissile phosphate. Even canonical seed pairing is dispensable for PIWI binding or cleavage, unlike plant and animal AGOs, which require uninterrupted target pairing from the seed to the nucleotides past the scissile bond3,4. PIWI proteins are therefore better equipped than AGO proteins to target newly acquired or rapidly diverging endogenous transposons without recourse to new small RNA guides. Conversely, the minimum requirements for PIWI slicing are sufficient to avoid inadvertent silencing of host RNAs. Our results demonstrate the biological advantage of PIWI over AGO proteins in defending the genome against transposons and suggest an explanation for why the piRNA pathway was retained in animal evolution.

4 February 2026 in Nature
Verified
Journal Article
Open access
PDF file
KCKatharine Cecchini
Katharine Cecchini
MZMina Zamani
Mina Zamani
NANandagopal Ajaykumar
Nandagopal Ajaykumar
JVJoel Vega-Badillo
Joel Vega-Badillo
ABAyca Bagci
Ayca Bagci
IGIldar Gainetdinov
Ildar Gainetdinov
Animals use 18–33-nucleotide PIWI-interacting RNAs (piRNAs) to silence transposons in germ cells 1–3 . In addition to transposon-silencing piRNAs, placental mammals make pachytene piRNAs 4,5 , an abundant class of testis-specific small RNAs derived from long noncoding RNA precursors. Although the sites of pachytene piRNA precursor transcription are often conserved among placental mammals, the sequences of the piRNAs themselves are rapidly diverging, even in the human population 6 . Consequently, the biological function and mechanism of action of pachytene piRNAs remain debated. Here we report that most mouse pachytene piRNAs have no biological function but instead ‘selfishly’ promote their own production. Our data suggest that pachytene piRNAs direct endonucleolytic cleavage of partially complementary targets and neither activate nor repress mRNA translation. Although many pachytene piRNAs guide cleavage of specific mRNAs, few alter the steady-state abundance of their targets. The minority of pachytene piRNAs that reduce target mRNA abundance enhance sperm fitness, thereby ensuring production of the entire pachytene piRNA repertoire. Together, our findings explain the lack of conservation of most pachytene piRNA sequences and suggest that these ‘selfish’ small RNAs persist in mammalian evolution because target cleavage by a tiny minority of piRNAs supports male fertility.

3 June 2023 in STAR Protocols
Verified
Journal Article
Open access
JVJoel Vega-Badillo
Joel Vega-Badillo
PZPhillip D. Zamore
Phillip D. Zamore
KJKarina Jouravleva
Karina Jouravleva
Binding affinity quantitatively describes the strength of a molecular interaction and is reported by the equilibrium dissociation constant (KD). Here, we present a protocol to measure KD of mammalian microRNA-loaded Argonaute2 protein by double filter binding. We describe steps for radiolabeling target RNA, measuring concentration of binding-competent protein, setting up binding reactions, separating protein-bound RNA from protein-unbound RNA, preparing library for Illumina sequencing, and performing data analysis. Our protocol is easily applied to other RNA- or DNA-binding proteins. For complete details on the use and execution of this protocol, please refer to Jouravleva et al.1.

16 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JVJoel Vega-Badillo
Joel Vega-Badillo
PZPhillip D. Zamore
Phillip D. Zamore
KJKarina Jouravleva
Karina Jouravleva
Summary: MicroRNAs-direct Argonaute proteins to repress complementary target mRNAs via mRNA degradation or translational inhibition. While mammalian miRNA targeting has been well studied, the principles by which Drosophila miRNAs bind their target RNAs remain to be fully characterized. Here, we use RNA Bind-n-Seq to systematically identify binding sites and measure their affinities for four highly expressed Drosophila miRNAs. Our results reveal a narrower range of binding site diversity in flies compared to mammals, with fly miRNAs favoring canonical seed-matched sites and exhibiting limited tolerance for imperfections within these sites. We also identified non-canonical site types, including nucleation-bulged and 3′-only sites, whose binding affinities are comparable to canonical sites. These findings establish a foundation for future computational models of Drosophila miRNA targeting, enabling predictions of regulatory outcomes in response to cellular signals, and advancing our understanding of miRNA- mediated regulation in flies.

20 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
JVJoel Vega-Badillo
Joel Vega-Badillo
PZPhillip D. Zamore
Phillip D. Zamore
KJKarina Jouravleva
Karina Jouravleva
MicroRNAs direct Argonaute proteins to repress complementary target mRNAs via mRNA degradation or translational inhibition. While mammalian miRNA targeting has been well studied, the principles by which Drosophila miRNAs bind their target RNAs remain to be fully characterized. Here, we use RNA Bind-n-Seq to systematically identify binding sites and measure their affinities for five highly expressed Drosophila miRNAs. Our results reveal a narrower range of binding site diversity in flies compared to mammals, with fly miRNAs favoring canonical seed-matched sites and exhibiting limited tolerance for imperfections within these sites. We also identified non-canonical site types, including nucleation-bulged and 3′-only sites, whose binding affinities are comparable to canonical sites. These findings establish a foundation for future computational models of Drosophila miRNA targeting, enabling predictions of regulatory outcomes in response to cellular signals, and advancing our understanding of miRNA-mediated regulation in flies.